The Minimal Clinically Important Difference and Substantial Clinical Benefit in the Patient-Reported Outcome Measures of Patients Undergoing Osteochondral Allograft Transplantation in the Knee | Zendy

Takahiro Ogura | Zendy; Jakob Ackermann | Zendy; Alexandre Barbieri Mestriner | Zendy; Gergő Merkely | Zendy; Andreas H. Gomoll | Zendy

Open Access

The Minimal Clinically Important Difference and Substantial Clinical Benefit in the Patient-Reported Outcome Measures of Patients Undergoing Osteochondral Allograft Transplantation in the Knee

Author(s) -

Takahiro Ogura,

Jakob Ackermann,

Alexandre Barbieri Mestriner,

Gergő Merkely,

Andreas H. Gomoll

Publication year - 2018

Publication title -

cartilage

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.705

H-Index - 33

eISSN - 1947-6043

pISSN - 1947-6035

DOI - 10.1177/1947603518812552

Subject(s) - minimal clinically important difference , medicine , prom , patient reported outcome , physical therapy , receiver operating characteristic , quality of life (healthcare) , transplantation , patient satisfaction , surgery , randomized controlled trial , nursing , obstetrics

Little is known regarding the minimal clinically important difference (MCID) and substantial clinical benefit (SCB) with regard to the Knee injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Lysholm score, and Short Form 12 (SF-12) score of patients who undergo osteochondral allograft transplantation (OCA). We aimed to determine the MCID and SCB associated with those patient-reported outcome measures (PROMs) after OCA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research